Hologic Acquires Endomagnetics (Endomag) for About $310 Million

April 29, 2024

Hologic signed a definitive agreement to acquire Endomagnetics Ltd (Endomag), a Cambridge, United Kingdom-based developer of breast cancer surgical guidance technologies, for approximately $310 million. The deal is subject to customary closing conditions, including regulatory approvals, and Endomag’s wireless breast surgery localization and lymphatic tracing solutions are expected to complement Hologic’s breast surgery portfolio.

Buyers
Hologic, Inc.
Targets
Endomagnetics Ltd (Endomag)
Industry
Medical Devices
Location
United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.